CLINICAL_TRIALS
trial_result
· 2021-04-26
Clinical Trial Update: MEK and MET Inhibition in Colorectal Cancer [Phase 1]
Summary
Phase 1 trial evaluating MEK and MET inhibition in colorectal cancer; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oxford | Conditions: Solid Tumor, Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-04-26